Logo
x

Search

Subscribe Now

Chronic autoimmune diseases

Organon and Samsung Bioepis Launch Hadlima (biosimilar, adalimumab)

Organon and Samsung Bioepis Launch Hadlima (biosimilar, adalimumab)

  • July 3, 2023
Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases

Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases

  • October 31, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.